# Evolution Report: Idea Tournament Round 2

## Date: 2026-03-21
## Type: IDE (Idea Direction Evolution)
## Trigger: Idea Tournament Round 2 completed

---

## Summary

Added 3 new feasible application directions from Idea Tournament Round 2 to Ideation Memory (M_I). These directions focus on demonstrating practical applications of GlycoSMILES2BAP with limited resources.

---

## Changes to M_I (Ideation Memory)

### New Directions Added

#### Direction 5: Antibody Fc Glycoform Optimization Case Study

- **Summary**: Create end-to-end case study demonstrating GlycoSMILES2BAP's value in therapeutic antibody development by predicting Fc glycoform structures and analyzing their impact on effector function.
- **Why Promising**: Highest Elo score (1620) in tournament; directly demonstrates drug development application; low resource requirements (public data available).
- **Requirements**: 3-5 Fc glycoform variants, AF3 predictions, structural analysis, literature validation.
- **Validation Plan**:
  1. Select representative Fc glycoforms (G0, G1, G2, afucosylated)
  2. Generate AF3 inputs using GlycoSMILES2BAP
  3. Predict Fc-glycan structures
  4. Compare structural features across glycoforms
  5. Validate against literature data
- **Evidence**: Idea Tournament Round 2 (2026-03-21), Rank #1, Elo 1620.
- **Status**: feasible
- **Related Entries**: GlyTouCan structural annotation database
- **Retrieval Tags**: antibody, Fc-glycan, drug-development, case-study, therapeutic
- **Date Added**: 2026-03-21

#### Direction 6: Glycan Structure Error Correction Case Collection

- **Summary**: Compile case studies demonstrating how GlycoSMILES2BAP corrects common stereochemistry errors in glycan structure prediction, highlighting the tool's unique value proposition.
- **Why Promising**: High novelty (9/10); unique angle showing error patterns; demonstrates practical debugging value; low resource requirements.
- **Requirements**: Error taxonomy, case selection, before/after comparisons, validation.
- **Validation Plan**:
  1. Identify common error patterns in glycan predictions
  2. Select representative error cases
  3. Apply GlycoSMILES2BAP to correct
  4. Document error → correction patterns
  5. Validate corrections
- **Evidence**: Idea Tournament Round 2 (2026-03-21), Rank #2, Elo 1595.
- **Status**: feasible
- **Related Entries**: Antibody Fc glycoform case study
- **Retrieval Tags**: error-correction, validation, debugging, case-study, quality-control
- **Date Added**: 2026-03-21

#### Direction 7: GlyTouCan Representative Subset Structural Annotation

- **Summary**: Create a database of predicted structures for a curated subset of GlyTouCan entries, demonstrating the pipeline's scalability and providing a community resource.
- **Why Promising**: High feasibility (9/10); creates valuable community resource; demonstrates scalability; low resource requirements.
- **Requirements**: GlyTouCan subset selection, batch processing, quality filtering, public release.
- **Validation Plan**:
  1. Select representative 500-1000 glycan subset
  2. Process through GlycoSMILES2BAP
  3. Filter by confidence scores
  4. Create browsable database
  5. Release with documentation
- **Evidence**: Idea Tournament Round 2 (2026-03-21), Rank #3, Elo 1585.
- **Status**: feasible
- **Related Entries**: Antibody Fc glycoform case study; Error correction cases
- **Retrieval Tags**: database, annotation, GlyTouCan, scalability, community-resource
- **Date Added**: 2026-03-21

---

## Changes to M_E (Experiment Memory)

### Idea Generation Strategies Added

#### Strategy IDEA-1: Tree-Structured Idea Expansion
- **Context**: When generating diverse research ideas for application scenarios
- **Approach**: Use 3-level tree expansion (Technique → Domain → Formulation) with systematic variation
- **Key Principle**: Each level varies one axis independently
  - Level 1 (Technique): Core approach variation
  - Level 2 (Domain): Application context variation
  - Level 3 (Formulation): Specific problem framing
- **Evidence**: Idea Tournament Round 2 produced 12 candidates from 3 techniques × 2 domains × N formulations
- **